182 related articles for article (PubMed ID: 2144560)
1. New drugs for Parkinson's disease.
Hodges LC; Rapp CG
J Neurosci Nurs; 1990 Aug; 22(4):254-7. PubMed ID: 2144560
[TBL] [Abstract][Full Text] [Related]
2. L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuations.
Cedarbaum JM; Toy LH; Green-Parsons A
Clin Neuropharmacol; 1991 Jun; 14(3):228-34. PubMed ID: 1906374
[TBL] [Abstract][Full Text] [Related]
3. Selegiline in the treatment of Parkinson's disease--long term experience.
Yahr MD; Elizan TS; Moros D
Acta Neurol Scand Suppl; 1989; 126():157-61. PubMed ID: 2515721
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of Parkinson's disease.
Ahlskog JE
Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977
[No Abstract] [Full Text] [Related]
5. What to do when Sinemet fails: Part one.
Klawans HL
Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
[No Abstract] [Full Text] [Related]
6. Parkinson's disease: recent advances in therapy.
Jankovic J
South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
[No Abstract] [Full Text] [Related]
7. Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease.
Cedarbaum JM; Breck L; Kutt H; McDowell FH
Neurology; 1987 Feb; 37(2):233-41. PubMed ID: 3808304
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
Brannan T; Yahr MD
Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
[TBL] [Abstract][Full Text] [Related]
9. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
Ahlskog JE; Muenter MD; McManis PG; Bell GN; Bailey PA
Mayo Clin Proc; 1988 Sep; 63(9):876-86. PubMed ID: 3045435
[TBL] [Abstract][Full Text] [Related]
10. Sinemet in Parkinson's disease: efficacy with and without food.
Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
[No Abstract] [Full Text] [Related]
11. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study.
Sage JI; Mark MH
Clin Neuropharmacol; 1988 Apr; 11(2):174-9. PubMed ID: 3378226
[No Abstract] [Full Text] [Related]
12. Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa.
Hutton JT; Morris JL; Román GC; Imke SC; Elias JW
Arch Neurol; 1988 Aug; 45(8):861-4. PubMed ID: 3395259
[TBL] [Abstract][Full Text] [Related]
13. Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
Hutton JT; Morris JL; Bush DF; Smith ME; Liss CL; Reines S
Neurology; 1989 Nov; 39(11 Suppl 2):67-72; discussion 72-3. PubMed ID: 2685652
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease.
Lieberman A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
[TBL] [Abstract][Full Text] [Related]
15. Sinemet CR in Parkinson's disease.
Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and Parkinson's disease: the CR FIRST Study.
Wasielewski PG; Koller WC
J Neurol; 1998 May; 245 Suppl 1():S28-30. PubMed ID: 9617720
[TBL] [Abstract][Full Text] [Related]
17. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
Goetz CG; Tanner CM; Klawans HL; Shannon KM; Carroll VS
Neurology; 1987 May; 37(5):875-8. PubMed ID: 3574696
[TBL] [Abstract][Full Text] [Related]
19. L-deprenyl in the treatment of Parkinson's disease.
Csanda E; Tárczy M; Takáts A; Mogyorós I; Köves A; Katona G
J Neural Transm Suppl; 1983; 19():283-90. PubMed ID: 6421993
[TBL] [Abstract][Full Text] [Related]
20. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
Goetz CG; Tanner CM; Shannon KM; Carroll VS; Klawans HL; Carvey PM; Gilley D
Neurology; 1988 Jul; 38(7):1143-6. PubMed ID: 3290706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
